Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 2 study of topical Fibrocaps plus gelatin sponge versus gelatin sponge alone for surgical hemostasis in liver resection
NL-OMON36279Phase 2Active, not recruiting
- Sponsor
- The Medicines Company
- Start
- Jan 2011
- Modality
- Recombinant Proteins and Enzymes, Device-based Delivery → Drug Delivery Systems
- Countries
- 1
01
Overview
Phase 2, randomised, single-blind trial of tachosil in Not applicable and Bleeding (2 arms), sponsored by The Medicines Company. Primary endpoint: Mean time to hemostasis. Started Jan 2011; status: active, not recruiting.
02
Drugs
tachosil
03
Conditions
Not applicableBleeding
Beyond the preview
Go deeper on NL-OMON36279.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON36279.